T3	Disorder 779 793	liver fibrosis
T5	Disorder 360 389	idiopathic pulmonary fibrosis
T9	GGPs 633 637	IL-5
T10	GGPs 627 631	IL-4
T15	Entity_Property 1275 1281	severe
T17	GGPs 639 644	IL-10
T19	Binding 1063 1070	binding
T20	Biological_process 1202 1221	granuloma formation
T25	Biological_process 208 225	tissue remodeling
T28	Disorder 1311 1330	portal hypertension
T31	Cellular_process 190 206	mucus production
T39	Disorder 352 358	asthma
T46	Anatomical_entity 601 606	liver
T48	Disorder 515 530	schistosomiasis
T50	Disorder 331 340	illnesses
T61	Entity_Property 1229 1242	chronic phase
T64	Disorder 1406 1421	schistosomiasis
T65	Disorder 1298 1306	fibrosis
T74	Disorder 575 592	chronic infection
T79	Disorder 391 409	ulcerative colitis
T80	GGPs 131 139	cytokine
T82	Disorder 436 444	diseases
E1	Binding:T19 Theme:T102 Theme2:T13
E2	Biological_process:T20 disorder:T34
E4	Biological_process:T25 
E5	Cellular_process:T31 
N12	Reference T3 UMLS:C0239946	Fibrosis, Liver
N16	Reference T5 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N31	Reference T9 UMLS:C1702088	IL5 protein, human
N74	Reference E1 UMLS:C1167622	Binding (Molecular Function)
N75	Reference E2 UMLS:C1817882	Granuloma formation
N94	Reference E4 UMLS:C1820201	tissue remodeling
N103	Reference T28 UMLS:C0020541	Hypertension, Portal
N109	Reference E5 UMLS:C2610947	mucus secretion
N136	Reference T39 UMLS:C0004096	Asthma
N162	Reference T46 UMLS:C0023884	Liver
N173	Reference T48 UMLS:C0036323	Schistosomiasis
N180	Reference T50 UMLS:C0221423	Illness (finding)
N217	Reference T61 UMLS:C0457343	Chronic phase
N227	Reference T64 UMLS:C0036323	Schistosomiasis
N229	Reference T65 UMLS:C0016059	Fibrosis
N259	Reference T74 UMLS:C0151317	Chronic infectious disease
N281	Reference T79 UMLS:C0009324	Ulcerative Colitis
N285	Reference T80 UMLS:C0079189	cytokine
N289	Reference T82 UMLS:C0012634	Disease
T93	Disorder 66 73	disease
N1	Reference T93 UMLS:C0012634	Disease
T94	Biological_process 176 188	inflammation
E14	Biological_process:T94 
N2	Reference E14 UMLS:C0021368	Inflammation
T95	Biological_process 232 240	fibrosis
E15	Biological_process:T95 
N5	Reference E15 UMLS:C0016059	Fibrosis
T7	Biological_process 607 616	pathology
E17	Biological_process:T7 Theme:T46
N11	Reference E17 UMLS:C0677042	Pathology processes
T42	Biological_process 694 729	granulomatous inflammatory response
E18	Biological_process:T42 
T44	Subject 1145 1152	Animals
T57	Disorder 1246 1255	infection
T85	Disorder 1358 1367	infection
N20	Reference T10 UMLS:C0021758	Interleukin-4
T55	GGPs 454 459	IL-13
N24	Reference T55 UMLS:C0214743	Interleukin-13
T97	GGPs 532 537	IL-13
N25	Reference T97 UMLS:C0214743	Interleukin-13
T98	GGPs 650 655	IL-13
N26	Reference T98 UMLS:C0214743	Interleukin-13
T99	GGPs 731 736	IL-13
N27	Reference T99 UMLS:C0214743	Interleukin-13
T100	GGPs 874 879	IL-13
N29	Reference T100 UMLS:C0214743	Interleukin-13
T101	GGPs 922 927	IL-13
N32	Reference T101 UMLS:C0214743	Interleukin-13
T102	GGPs 1057 1062	IL-13
N33	Reference T102 UMLS:C0214743	Interleukin-13
T103	GGPs 1138 1143	IL-13
N34	Reference T103 UMLS:C0214743	Interleukin-13
T104	GGPs 1282 1287	IL-13
N35	Reference T104 UMLS:C0214743	Interleukin-13
T105	GGPs 1470 1475	IL-13
N36	Reference T105 UMLS:C0214743	Interleukin-13
T106	GGPs 19 24	IL-13
N38	Reference T106 UMLS:C0214743	Interleukin-13
T6	GGPs 76 95	Interleukin (IL)-13
N21	Reference T6 UMLS:C0214743	Interleukin-13
T1	GGPs 29 51	IL-13 receptor alpha 2
N3	Reference T1 UMLS:C0968296	Interleukin-13 Receptor alpha2 Subunit
T13	GGPs 1071 1092	chain, IL-13R alpha 2
N4	Reference T13 UMLS:C0968296	Interleukin-13 Receptor alpha2 Subunit
T14	GGPs 1166 1180	IL-13R alpha 2
N22	Reference T14 UMLS:C0968296	Interleukin-13 Receptor alpha2 Subunit
T16	GGPs 1480 1494	IL-13R alpha 2
N39	Reference T16 UMLS:C0968296	Interleukin-13 Receptor alpha2 Subunit
T22	Pathway 922 937	IL-13 signaling
E7	Pathway:T22 Participant:T101
N40	Reference E7 UMLS:C3158959	interleukin-13-mediated signaling pathway
T32	Positive_regulation 941 949	mediated
E8	Positive_regulation:T32 Theme:E7 Cause:T24
N44	Reference E8 UMLS:C1879547	Activation action
T36	GGPs 1001 1012;1032 1038	IL-4R alpha chains
N23	Reference T36 UMLS:C1721038	Interleukin-4 Receptor alpha Subunit
T24	GGPs 957 977	type-2 IL-4 receptor
N46	Reference T24 UMLS:C1721037	Receptors, Interleukin-4, Type II
T27	GGPs 1017 1038	IL-13R alpha 1 chains
N45	Reference T27 UMLS:C0527729	Interleukin-13 Receptor alpha1 Subunit
R2	part_of Arg1:T36 Arg2:T24	
R3	part_of Arg1:T27 Arg2:T24	
N47	Reference T17 UMLS:C0085295	Interleukin-10
T35	Subject 499 511	murine model
N48	Reference T35 UMLS:C2986594	Mouse Model
R1	Subject_Disorder Arg1:T35 Arg2:T48	
N10	Reference T15 UMLS:C0205082	Severe (severity modifier)
T37	Positive_regulation 105 112	inducer
E3	Positive_regulation:T37 Cause:T6 Theme:E20
N49	Reference E3 UMLS:C1879547	Activation action
T40	Positive_regulation 593 600	induced
E6	Positive_regulation:T40 Cause:T74 Theme:E17
N50	Reference E6 UMLS:C1879547	Activation action
T49	Negative_regulation 1114 1121	inhibit
E9	Negative_regulation:T49 Theme:E24 Cue:T26 Cause:T13
N51	Reference E9 UMLS:C3463820	Inhibition
T51	Negative_regulation 1189 1201	downmodulate
E10	Negative_regulation:T51 Cue:T30 Theme:E2
N52	Reference E10 UMLS:C3463820	Inhibition
T43	Positive_regulation 166 175	regulates
E13	Positive_regulation:T43 Theme:E14
N53	Reference E13 UMLS:C1879547	Activation action
T52	Positive_regulation 661 669	regulate
E19	Positive_regulation:T52 Cause:T10 Theme:E18
N54	Reference E19 UMLS:C1879547	Activation action
T18	Biological_process 1267 1274	develop
E11	Biological_process:T18 Theme:T68
N56	Reference E11 UMLS:C0699748	Pathogenesis
E12	Biological_process:T18 Theme:T69
N57	Reference E12 UMLS:C0699748	Pathogenesis
T58	Gene_expression 478 490	overproduced
E21	Gene_expression:T58 Theme:T55 disorder:T82
N59	Reference E21 UMLS:C0017262	Gene Expression
T62	Gene_expression 846 856	production
E23	Gene_expression:T62 Theme:T100
N61	Reference E23 UMLS:C0017262	Gene Expression
T12	Molecular_function 1126 1134	activity
E24	Molecular_function:T12 Theme:T103
N43	Reference E24 UMLS:C1148560	molecular_function
T63	Molecular_function 862 870	function
E25	Molecular_function:T63 Theme:T100
N62	Reference E25 UMLS:C1148560	molecular_function
T67	Molecular_function 1455 1465	activities
E26	Molecular_function:T67 Theme:T105 Cue:T66
N63	Reference E26 UMLS:C1148560	molecular_function
T21	Positive_regulation 833 841	regulate
E27	Positive_regulation:T21 Theme:E23
N64	Reference E27 UMLS:C1879547	Activation action
T68	Disorder 1275 1281;1298 1306	severe fibrosis
N65	Reference T68 UMLS:C0016059	Fibrosis
T69	Disorder 1275 1281;1311 1330	severe portal hypertension
N66	Reference T69 UMLS:C0020541	Hypertension, Portal
T71	Entity_Property 1275 1281	severe
N67	Reference T71 UMLS:C0205082	Severe (severity modifier)
R4	member_of Arg1:T68 Arg2:T65	
R5	member_of Arg1:T69 Arg2:T28	
T34	Disorder 1229 1255	chronic phase of infection
R6	member_of Arg1:T34 Arg2:T57	
N18	Reference T57 UMLS:C0009450	Communicable Diseases
N55	Reference T34 UMLS:C0009450	Communicable Diseases
N19	Reference T85 UMLS:C0009450	Communicable Diseases
N17	Reference T44 UMLS:C0003062	Animals
R7	member_of Arg1:T39 Arg2:T50	
R8	member_of Arg1:T5 Arg2:T50	
R9	member_of Arg1:T79 Arg2:T50	
R10	member_of Arg1:T82 Arg2:T50	
T56	Positive_regulation 563 571	mediator
E16	Positive_regulation:T56 Cause:T97 Theme:E17 disorder:T48
N58	Reference E16 UMLS:C1879547	Activation action
T59	Biological_process 150 161	pathologies
E20	Biological_process:T59 
N68	Reference E20 UMLS:C0677042	Pathology processes
T38	GGPs 124 139	type-2 cytokine
R11	member_of Arg1:T38 Arg2:T80	
E22	Positive_regulation:T43 Theme:E5
N60	Reference E22 UMLS:C1879547	Activation action
E28	Positive_regulation:T43 Theme:E4
N69	Reference E28 UMLS:C1879547	Activation action
E29	Positive_regulation:T43 Theme:E15
N70	Reference E29 UMLS:C1879547	Activation action
T54	Positive_regulation 767 775	mediator
E30	Positive_regulation:T54 Cause:T99 Theme:T3
N8	Reference E30 UMLS:C1879547	Activation action
E31	Positive_regulation:T52 Cause:T9 Theme:E18
N13	Reference E31 UMLS:C1879547	Activation action
E32	Positive_regulation:T52 Cause:T17 Theme:E18
N71	Reference E32 UMLS:C1879547	Activation action
E33	Positive_regulation:T52 Cause:T98 Theme:E18
N72	Reference E33 UMLS:C1879547	Activation action
E34	Positive_regulation:T21 Theme:E25
N73	Reference E34 UMLS:C1879547	Activation action
T30	Negation_cue 1181 1188	fail to
A1	Negated E10
E35	Molecular_function:T67 Theme:T16 Cue:T66
N76	Reference E35 UMLS:C1148560	molecular_function
T53	Positive_regulation 1288 1297	dependent
E36	Positive_regulation:T53 Cause:T104 Theme:T68
N77	Reference E36 UMLS:C1879547	Activation action
T60	Positive_regulation 140 149	dependent
E37	Positive_regulation:T60 Cause:T38 Theme:E20
N78	Reference E37 UMLS:C1879547	Activation action
N14	Reference E18 UMLS:C0553697	Granulomatous inflammation
T26	Speculation_cue 1094 1101	appears
A2	Speculated E9
R12	Subject_Disorder Arg1:T44 Arg2:T34	
T66	Speculation_cue 1435 1445	illustrate
A3	Speculated E35
A4	Speculated E26
E38	Positive_regulation:T53 Cause:T104 Theme:T69
N79	Reference E38 UMLS:C1879547	Activation action
